- Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trialShen, Yuanming; Kong, Beihua; Xia, Bairong; Wang, Fei; Yin, Rutie; Li, Qingshui; Yue, Ying; Kang, Shan; He, Liping; Wang, Ke; Meng, Yuanguang; Wang, Shixuan; Qu, Pengpeng; Huang, Xianghua; Guo, Ruixia; Yan, Ping; Pan, Mei; Lou, Ge; Cheng, Wenjun; Xie, XingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Mitoxantrone hydrochloride liposome injection in the treatment of recurrent/metastatic head and neck cancers: A multicenter, open-label, single-arm, phase Ib study.Yang, Hang; Wang, Xicheng; Zhang, Hong; Peng, Jiyong; Li, Weidong; Liu, Yanyan; Hu, Jianbing; Zhou, Hui; Zhang, Bing; Liu, Jixiang; Lin, Shunhuan; Luo, Hao; Hu, Jie; Li, ZhimingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
- Advances in Ovarian Cancer and Ongoing Clinical TrialsValeria, Masciullo; Cristina, Di Cesare; Ida, ParisGynecological Cancers, Springer International Publishing, 65-77, 2016.
会议论文
Safety and efficacy of mitoxantrone hydrochloride liposome in patients with platinum-refractory or platinum-resistant ovarian cancer: A prospective, multicenter, open-label, single-arm, phase Ib clinical trial.
5阅读
